OR51E2 activation results in anti-proliferative effect and metastasis in prostate cancer cells, anti-proliferative effect and melanogenesis in melanocytes and proliferation and metastasis in retinal pigment epithelial cells. The gene discussed is OR51E2; the disease is Familial prostate cancer.